Publications: Prof Robert Walton
Garcia Gonzalez J, Brock A, Parker M, Riley R, Joliffe D, SUDWARTS A, Teh M-T, Busch-Nentwich E et al.(2020).
Identification of Slit3 as a locus affecting nicotine preference in zebrafish and human smoking behaviour. eLife
Steed L, Sohanpal R, Todd A, Madurasinghe VW, Rivas C, Edwards EA, Summerbell CD, Taylor SJC et al.(2019).
Community pharmacy interventions for health promotion: effects on professional practice and health outcomes. Cochrane Database of Systematic Reviews
vol. 2019,
(12)
Hui CY, Walton R, McKinstry B, Pinnock H(2019).
Time to change the paradigm? A mixed method study of the preferred and potential features of an asthma self-management app. Health Informatics J
Sohanpal R, Jumbe S, James WY, Steed L, Yau T, Rivas C, Madurasinghe V, Houlihan C et al.(2019).
Evaluating the effectiveness and cost-effectiveness of the Smoking Treatment Optimisation in Pharmacies (STOP) intervention: Protocol for a cluster randomised controlled trial. Trials
vol. 20,
(1)
Madurasinghe V, Jumbe S, James W, Steed L, SOHANPAL R, Yau T, Taylor S, Eldridge S et al.(2019).
Evaluating NHS Stop Smoking Service engagement in community pharmacies using simulated smokers: fidelity assessment of a theory-based intervention. BMJ Open
Hui CY, McKinstry B, Walton R, Pinnock H(2019).
A mixed method observational study of strategies to promote adoption and usage of an application to support asthma self-management. J Innov Health Inform
vol. 25,
(4)
243-253.
Steed L, Sohanpal R, Todd A, Madurasinghe VW, Rivas C, Edwards EA, Summerbell CD, Taylor SJC et al.(2019).
Community pharmacy interventions for health promotion: effects on professional practice and health outcomes. COCHRANE DATABASE OF SYSTEMATIC REVIEWS
(12)
Article ARTN CD011207,
Mudway IS, Dundas I, Wood HE, Marlin N, Jamaludin JB, Bremner SA, Cross L, Grieve A et al.(2019).
Impact of London's low emission zone on air quality and children's respiratory health: a sequential annual cross-sectional study. The Lancet Public Health
vol. 4,
(1)
e28-e40.
Shenvi A, Smith JQ, Walton R, Eldridge S (2019).
Modelling with non-stratified chain event graphs. Springer Proceedings in Mathematics and Statistics.
vol. 296,
155-163.
James WY, Jumbe S, Houlihan C, Madurasinghe V, Taylor S, Eldridge S, Griffiths C, Walton R(2019).
Recruiting community pharmacies to a smoking support service trial using the 'Russian doll' approach. Clinical Pharmacist
vol. 11,
(1)
Edwards EA, Caton H, Lumsden J, Rivas C, Steed L, Pirunsarn Y, Jumbe S, Newby C et al.(2018).
Creating a Theoretically Grounded, Gamified Health App: Lessons From Developing the Cigbreak Smoking Cessation Mobile Phone Game. JMIR Serious Games
vol. 6,
(4)
MADURASINGHE VW, ELDRIDGE S, GRIFFITHS C(2018).
Case finding and therapy for chronic viral hepatitis in primary care (HepFREE): a cluster-randomised controlled trial. The Lancet Gastroenterology & Hepatology
James WY, Jumbe S, Madurasinghe V, Eldridge S, Taylor S, Houlihan C, Griffiths C, Walton R (2018).
Supporting recruitment of community pharmacies for the STOP trial training using an embedded recruitment model ( Russian doll approach). EUROPEAN RESPIRATORY JOURNAL.
vol. 52,
Jolliffe DA, Greiller CL, Mein CA, Hoti M, Bakhsoliani E, Telcian AG, Simpson A, Barnes NC et al.(2018).
Vitamin D receptor genotype influences risk of upper respiratory infection. Br J Nutr1-10.
Madurasinghe VW, Sohanpal R, James W, Steed L, Eldridge S, Taylor SJC, Griffiths C, Walton R(2017).
Smoking treatment optimisation in pharmacies (STOP): A cluster randomised pilot trial of a training intervention. Pilot and Feasibility Studies
vol. 3,
(1)
Yindom L-M, Mendy M, Bodimeade C, Chambion C, Aka P, Whittle HC, Rowland-Jones SL, Walton R(2017).
KIR content genotypes associate with carriage of hepatitis B surface antigen, e antigen and HBV viral load in Gambians. PLoS One
vol. 12,
(11)
Article 0188307,
e0188307-e0188307.
O'Hara GA, McNaughton AL, Maponga T, Jooste P, Ocama P, Chilengi R, Mokaya J, Liyayi MI et al.(2017).
Hepatitis B virus infection as a neglected tropical disease. PLoS Negl Trop Dis
vol. 11,
(10)
e0005842-e0005842.
Rivas C, Sohanpal R, Macneill V, Steed L, Edwards E, Antao L, Griffiths C, Eldridge S et al.(2017).
Determining counselling communication strategies associated with successful quits in the National Health Service community pharmacy Stop Smoking programme in East London: A focused ethnography using recorded consultations. BMJ Open
vol. 7,
(10)
Lindsey L, Husband A, Steed L, Walton R, Todd A(2017).
Helpful advice and hidden expertize: pharmacy users' experiences of community pharmacy accessibility. J Public Health (Oxf)
vol. 39,
(3)
609-615.
Steed L, Sohanpal R, James W-Y, Rivas C, Jumbe S, Chater A, Todd A, Edwards E et al.(2017).
Equipping community pharmacy workers as agents for health behaviour change: developing and testing a theory-based smoking cessation intervention. BMJ Open
vol. 7,
(8)
e015637-e015637.
Madurasinghe V, Eldridge S, Sohanpal R, James W, Steed L, Taylor S, Griffiths C, Walton R (2017).
Challenges of conducting clinical trials in community pharmacies and their methodological implications: pilot trial of a training intervention for smoking treatment optimisation in pharmacies (STOP).
vol. 18,
Jolliffe DA, James WY, Hooper RL, Barnes NC, Greiller CL, Islam K, Bhowmik A, Timms PM et al.(2017).
Prevalence, determinants and clinical correlates of vitamin D deficiency in patients with Chronic Obstructive Pulmonary Disease in London, UK. Journal of Steroid Biochemistry and Molecular Biology
Hui CY, Walton R, McKinstry B, Jackson T, Parker R, Pinnock H(2017).
The use of mobile applications to support self-management for people with asthma: A systematic review of controlled studies to identify features associated with clinical effectiveness and adherence. Journal of the American Medical Informatics Association
vol. 24,
(3)
619-632.
GRIGG JM(2016).
Urinary prostanoids in preschool wheeze. European Respiratory Journal
Greenhalgh T, Macfarlane F, Steed L, Walton R(2016).
What works for whom in pharmacist-led smoking cessation support: realist review. BMC Med
vol. 14,
(1)
209-209.
Polanska K, Krol A, Kaluzny P, Ligocka D, Mikolajewska K, Shaheen S, Walton R, Hanke W(2016).
Estimation of Saliva Cotinine Cut-Off Points for Active and Passive Smoking during Pregnancy-Polish Mother and Child Cohort (REPRO_PL). Int J Environ Res Public Health
vol. 13,
(12)
Griffiths CJ, Mudway I, Wood H, Marlin N, Dundas I, Walton R, Grigg J, Sheikh A et al. (2016).
IMPACT OF THE LONDON LOW EMISSION ZONE ON CHILDREN'S RESPIRATORY HEALTH: A SEQUENTIAL YEARLY CROSS SECTIONAL STUDY 2008-2014.
vol. 71,
pp. A182-A182.
Jolliffe DA, Kilpin K, MacLaughlin BD, Greiller CL, Hooper RL, Barnes NC, Timms PM, Rajakulasingam RK et al.(2016).
Prevalence, determinants and clinical correlates of vitamin D deficiency in adults with inhaled corticosteroid-treated asthma in London, UK. J Steroid Biochem Mol Biol
Walton RT, Mudway IS, Dundas I, Marlin N, Koh LC, Aitlhadj L, Vulliamy T, Jamaludin JB et al.(2016).
Air pollution, ethnicity and telomere length in east London schoolchildren: An observational study. Environment International
vol. 96,
41-47.
Jolliffe DA, Hanifa Y, Witt KD, Venton TR, Rowe M, Timms PM, Hyppönen E, Walton RT et al.(2016).
Environmental and genetic determinants of vitamin D status among older adults in London, UK. Journal of Steroid Biochemistry and Molecular Biology
vol. 164,
30-35.
Jolliffe DA, Walton RT, Griffiths CJ, Martineau AR(2016).
Single nucleotide polymorphisms in the vitamin D pathway associating with circulating concentrations of vitamin D metabolites and non-skeletal health outcomes: Review of genetic association studies. Journal of Steroid Biochemistry and Molecular Biology
vol. 164,
18-29.
Edwards EA, Lumsden J, Rivas C, Steed L, Edwards LA, Thiyagarajan A, Sohanpal R, Caton H et al.(2016).
Gamification for health promotion: systematic review of behaviour change techniques in smartphone apps. BMJ Open
vol. 6,
(10)
e012447-e012447.
Sohanpal R, Rivas C, Steed L, MacNeill V, Kuan V, Edwards E, Griffiths C, Eldridge S et al.(2016).
Understanding recruitment and retention in the NHS community pharmacy stop smoking service: Perceptions of smoking cessation advisers. BMJ Open
vol. 6,
(7)
Wood HE, Marlin N, Mudway IS, Bremner SA, Cross L, Dundas I, Grieve A, Grigg J et al.(2015).
Effects of air pollution and the introduction of the London Low Emission Zone on the prevalence of respiratory and allergic symptoms in schoolchildren in east London: A sequential cross-sectional study. PLoS ONE
vol. 10,
(8)
Martineau AR, MacLaughlin BD, Hooper RL, Barnes NC, Jolliffe DA, Greiller CL, Kilpin K, McLaughlin D et al.(2015).
Double-blind randomised placebo-controlled trial of bolus-dose vitamin D<inf>3</inf> supplementation in adults with asthma (ViDiAs). Thorax
vol. 70,
(5)
451-457.
Jolliffe DA, Martineau AR, Maclaughlin BM, Kiplin KK, Timms PMT, Mein CAM, Walton RW, Griffiths CJG (2014).
PREVALENCE AND DETERMINANTS OF VITAMIN D DEFICIENCY IN ASTHMA PATIENTS. THORAX.
vol. 69,
A94-A95.
Jolliffe DA, Martineau AR, James WYJ, Islam KI, Mein CAM, Timms PMT, Walton RW, Griffiths CJG (2014).
PREVALENCE AND DETERMINANTS OF VITAMIN D DEFICIENCY IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE. THORAX.
vol. 69,
A215-A216.
Fong FM, Sahemey MK, Hamedi G, Eyitayo R, Yates D, Kuan V, Thangaratinam S, Walton RT(2014).
Maternal genotype and severe preeclampsia: a HuGE review. Am J Epidemiol
vol. 180,
(4)
335-345.
Steed L, Kassavou A, Madurasinghe VW, Edwards EA, Todd A, Summerbell CD, Nkansah N, Bero L et al.(2014).
Community pharmacy interventions for health promotion: Effects on professional practice and health outcomes. Cochrane Database of Systematic Reviews
vol. 2014,
(7)
Janha RE, Worwui A, Linton KJ, Shaheen SO, Sisay-Joof F, Walton RT(2014).
Inactive alleles of cytochrome P450 2C19 may be positively selected in human evolution. BMC Evol Biol
vol. 14,
Vawda S, Mansour R, Takeda A, Funnell P, Kerry S, Mudway I, Jamaludin J, Shaheen S et al.(2014).
Associations between inflammatory and immune response genes and adverse respiratory outcomes following exposure to outdoor air pollution: a HuGE systematic review. Am J Epidemiol
vol. 179,
(4)
432-442.
Secka O, Moodley Y, Antonio M, Berg DE, Tapgun M, Walton R, Worwui A, Thomas V et al.(2014).
Population genetic analyses of Helicobacter pylori isolates from Gambian adults and children. PLoS One
vol. 9,
(10)
Dundas I, Marlin N, Jamaludin J, Mudway I, Wood H, Cross L, McLaughlin D, Schwappach A et al.(2013).
Ethnic and nutritional determinants of respiratory function in East London children. EUROPEAN RESPIRATORY JOURNAL
vol. 42,
Griffiths C, Mudway I, Wood H, Dundas I, Cross L, Marlin N, Jamaludin J, Bremner S et al.(2013).
Impact of traffic-related pollution on respiratory function in children living in London's low emission zone: A sequential cross sectional study. EUROPEAN RESPIRATORY JOURNAL
vol. 42,
Kuan V, Martineau AR, Griffiths CJ, Hyppönen E, Walton R(2013).
DHCR7 mutations linked to higher vitamin D status allowed early human migration to northern latitudes. BMC Evol Biol
vol. 13,
Parker MO, Brock AJ, Walton RT, Brennan CH(2013).
The role of zebrafish (Danio rerio) in dissecting the genetics and neural circuits of executive function. Frontiers in Neural Circuits
(MAR)
Secka O, Berg DE, Antonio M, Corrah T, Tapgun M, Walton R, Thomas V, Galano JJ et al.(2013).
Antimicrobial susceptibility and resistance patterns among Helicobacter pylori strains from The Gambia, West Africa. Antimicrob Agents Chemother
vol. 57,
(3)
1231-1237.
Adetifa IM, Ota MOC, Jeffries DJ, Lugos MD, Hammond AS, Battersby NJ, Owiafe PK, Donkor SD et al.(2013).
Interferon-γ ELISPOT as a biomarker of treatment efficacy in latent tuberculosis infection: a clinical trial. Am J Respir Crit Care Med
vol. 187,
(4)
439-445.
Griffiths C, Patel D, Akporobaro A, Chinyanganya N, Hackshaw A, Seale C, Walton R, Spiro S(2012).
Need to test impact of DNA-based risk scores. Thorax
vol. 67,
(9)
Walther M, De Caul A, Aka P, Njie M, Amambua-Ngwa A, Walther B, Predazzi IM, Cunnington A et al.(2012).
HMOX1 gene promoter alleles and high HO-1 levels are associated with severe malaria in Gambian children. PLoS Pathog
vol. 8,
(3)
Jamaludin J, Kelly FJ, Griffiths C, Walton R, Dundas I, Mudway IS, et al.(2012).
Neither acute nor chronic exposure to nitrogen dioxide is associated with altered lung function in children living in inner London. Free Radical Biology and Medicine
vol. 53,
(Supplement 1)
S230-S231.
Tucker MR, Walton R, Matthews H, Miskin A (2011).
Method and Kit for Assessing a Patient's Genetic Information, Lifestyle and Environment Conditions, and Providing a Tailored Therapeutic Regime.
no. US 12/944,372,
Secka O, Thomas JE, Berg DE, Antonio M, Tapgun M, Thomas V, Walton R, Corrah T et al. (2011).
PREVALENCE OF CAGA AND VACA GENES IN HELICOBACTER PYLORI FROM THE GAMBIA IN RELATION TO DISEASE PHENOTYPE. HELICOBACTER.
vol. 16,
102-102.
Brock AJ, Takeda A, Brennan C, Walton RT(2011).
Treatment for tobacco dependence: a potential application for stratified medicine?. PERS MED
vol. 8,
(5)
571-579.
Secka O, Antonio M, Tapgun M, Berg DE, Bottomley C, Thomas V, Walton R, Corrah T et al.(2011).
PCR-based genotyping of Helicobacter pylori of Gambian children and adults directly from biopsy specimens and bacterial cultures. Gut Pathog
vol. 3,
(1)
Secka O, Antonio M, Berg DE, Tapgun M, Bottomley C, Thomas V, Walton R, Corrah T et al.(2011).
Mixed infection with cagA positive and cagA negative strains of Helicobacter pylori lowers disease burden in The Gambia. PLoS One
vol. 6,
(11)
Dunyo S, Sirugo G, Sesay S, Bisseye C, Njie F, Adiamoh M, Nwakanma D, Diatta M et al.(2011).
Randomized Trial of Safety and Effectiveness of Chlorproguanil-Dapsone and Lumefantrine-Artemether for Uncomplicated Malaria in Children in The Gambia. PloS one
vol. 6,
Article 6,
e17371-e17371.
Hanifa Y, Walton R(2011).
Vitamin D and Acute Respiratory Tract Infection. Current Respiratory Medicine Reviews
vol. 7,
Article 6,
421-434.
Yindom L-M, Leligdowicz A, Martin MP, Gao X, Qi Y, Zaman SMA, van der Loeff MS, van Tienen C et al.(2010).
Influence of HLA class I and HLA-KIR compound genotypes on HIV-2 infection and markers of disease progression in a Manjako community in West Africa. J Virol
vol. 84,
(16)
8202-8208.
Walton R, Mckinney E, Marshall S, Murphy M, Welsh K (2010).
Genetic indicators of tobacco consumption.
no. 10/130,907,
Mendy M, Walton R(2009).
Molecular pathogenesis and early detection of hepatocellular carcinoma - Perspectives from West Africa. CANCER LETT
vol. 286,
(1)
44-51.
Janha RE, Sisay-Joof F, Hamid-Adiamoh M, Worwui A, Chapman HL, Opara H, Dunyo S, Milligan P et al.(2009).
Effects of genetic variation at the CYP2C19/CYP2C9 locus on pharmacokinetics of chlorcycloguanil in adult Gambians. Pharmacogenomics
vol. 10,
Article 9,
1423-1431.
Johnstone E, Munafò M, Neville M, Griffiths S, Murphy M, Walton R(2009).
Pharmacogenomics of tobacco addiction. Pharmacogenomics
David SP, Munafo MR, Murphy MFG, Proctor M, Walton RT, Johnstone EC(2008).
Genetic variation in the dopamine D4 receptor (DRD4) gene and smoking cessation: follow-up of a randomised clinical trial of transdermal nicotine patch. PHARMACOGENOMICS JOURNAL
vol. 8,
(2)
122-128.
Durieux P, Trinquart L, Colombet I, Nies J, Walton R, Rajeswaran A, Rege Walther M, Harvey E et al.(2008).
Computerized advice on drug dosage to improve prescribing practice. Cochrane Database Syst Rev
vol. 3,
Walton RT, Rowland-Jones SL(2008).
HIV and Chemokine Binding to Red Blood Cells—DARC Matters. Cell Host & Microbe
vol. 4,
Article 1,
3-5.
David SP, Munafò MR, Johansen-Berg H, Mackillop J, Sweet LH, Cohen RA, Niaura R, Rogers RD et al.(2007).
Effects of Acute Nicotine Abstinence on Cue-elicited Ventral Striatum/Nucleus Accumbens Activation in Female Cigarette Smokers: A Functional Magnetic Resonance Imaging Study. Brain Imaging Behav
vol. 1,
(3-4)
43-57.
Munafo MR, Elliot KM, Murphy MFG, Walton RT, Johnstone EC(2007).
Association of the mu-opioid receptor gene with smoking cessation. PHARMACOGENOMICS JOURNAL
vol. 7,
(5)
353-361.
Johnstone EC, Elliot KM, David SP, Murphy MFG, Walton RT, Munafò MR(2007).
Association of COMT Val108/158Met genotype with smoking cessation in a nicotine replacement therapy randomized trial. Cancer Epidemiol Biomarkers Prev
vol. 16,
(6)
1065-1069.
Tucker MR, Walton R, Matthews H, Miskin A (2007).
Method and Kit for Assessing a Patient's Genetic Information, Lifestyle and Environment Conditions, and Providing a Tailored Therapeutic Regime.
no. 11/530,826,
David SP, Munafo MR, Murphy MFG, Walton RT, Johnstone EC(2007).
The serotonin transporter 5-HTTLPR polymorphism and treatment response to nicotine patch: Follow-up of a randomized controlled trial. NICOTINE & TOBACCO RESEARCH
vol. 9,
(2)
225-231.
Tyndale RF, Shiffman S, Brody AL, Clarke PBS, Walton R, Jarvis MJ, Hajek P, West R et al.(2006).
Discussion. Novartis Foundation Symposium
vol. 275,
231-234.
West R, Markou A, Peto R, Perkins K, Shiffman S, Clarke PBS, Walton R, Bertrand D et al.(2006).
General discussion II. Novartis Foundation Symposium
vol. 275,
197-203.
Walton R(2006).
Pharmacogenomics and smoking cessation. Novartis Foundation Symposium
vol. 275,
184-194.
Johnstone E, Benowitz N, Cargill A, Jacob R, Hinks L, Day I, Murphy M, Walton R(2006).
Determinants of the rate of nicotine metabolism and effects on smoking behavior. Clin Pharmacol Ther
vol. 80,
(4)
319-330.
Quiroga I, Sweeney D, Sutton PM, Ahmad T, Walton R, Barnardo MCNM, Fuggle SV(2006).
The identification of three novel MICA alleles by sequence-based typing. Tissue Antigens
vol. 67,
(4)
321-325.
David SP, Munafò MR, Johansen-Berg H, Smith SM, Rogers RD, Matthews PM, Walton RT(2005).
Ventral striatum/nucleus accumbens activation to smoking-related pictorial cues in smokers and nonsmokers: a functional magnetic resonance imaging study. Biol Psychiatry
vol. 58,
(6)
488-494.
Walton R, Kimber M, Rockett K, Trafford C, Kwiatkowski D, Sirugo G(2005).
Haplotype block structure of the cytochrome P450CYP2C gene cluster on chromosome 10. NATURE GENETICS
vol. 37,
(9)
915-916.
Aveyard P, Johnson CJ, Murphy M, Walton R, Drury M, Brown K(2005).
A randomized controlled trial of nortriptyline-nrt treatment vs. placebo-NRT treatment in quitting smoking. NICOTINE & TOBACCO RESEARCH
vol. 7,
(4)
649-649.
Munafò MR, Lingford-Hughes AR, Johnstone EC, Walton RT(2005).
Association between the serotonin transporter gene and alcohol consumption in social drinkers. American Journal of Medical Genetics - Neuropsychiatric Genetics
vol. 135 B,
(1)
10-14.
David SP, Murthy NV, Rabiner EA, Munafó MR, Johnstone EC, Jacob R, Walton RT, Grasby PM(2005).
A functional genetic variation of the serotonin (5-HT) transporter affects 5-HT1A receptor binding in humans. J Neurosci
vol. 25,
(10)
2586-2590.
Munafo MR, Roberts K, Johnstone EC, Walton RT, Yudkin PL(2005).
Association of serotonin transporter gene polymorphism with nicotine dependence: no evidence for an interaction with trait neuroticism. PERSONALITY AND INDIVIDUAL DIFFERENCES
vol. 38,
(4)
843-850.
Munafò MR, Johnstone EC, Welsh KI, Walton RT(2005).
Association between the DRD2 gene Taq1A (C32806T) polymorphism and alcohol consumption in social drinkers. Pharmacogenomics J
vol. 5,
(2)
96-101.
Murthy NY, David S, Rabiner EA, Johnstone E, Jacob R, Walton R, Grasby PM (2004).
A functional genetic variation of the 5-HT transporter affects 5-HT1A receptor binding in humans. JOURNAL OF PSYCHOPHARMACOLOGY.
vol. 18,
A68-A68.
Johnstone EC, Yudkin P, Griffiths SE, Fuller A, Murphy M, Walton R(2004).
The dopamine D2 receptor C32806T polymorphism (DRD2 Taq1A RFLP) exhibits no association with smoking behaviour in a healthy UK population. Addict Biol
vol. 9,
(3-4)
221-226.
Johnstone E, Hey K, Drury M, Roberts S, Welch S, Walton R, Murphy M(2004).
Zyban for smoking cessation in a general practice setting: the response to an invitation to make a quit attempt. Addict Biol
vol. 9,
(3-4)
227-232.
Jacob RM, Johnstone EC, Neville MJ, Walton RT(2004).
Identification of CYP2B6 sequence variants by use of multiplex PCR with allele-specific genotyping. Clin Chem
vol. 50,
(8)
1372-1377.
Munafò M, Clark T, Johnstone E, Murphy M, Walton R(2004).
The genetic basis for smoking behavior: a systematic review and meta-analysis. Nicotine Tob Res
vol. 6,
(4)
583-597.
Neville MJ, Johnstone EC, Walton RT(2004).
Identification and characterization of ANKK1: a novel kinase gene closely linked to DRD2 on chromosome band 11q23.1. Hum Mutat
vol. 23,
(6)
540-545.
Low JH, Williams FA, Yang X, Cullen S, Colley J, Ling KL, Armuzzi A, Ahmad T et al.(2004).
Inflammatory bowel disease is linked to 19p13 and associated with ICAM-1. Inflamm Bowel Dis
vol. 10,
(3)
173-181.
Yudkin P, Munafò M, Hey K, Roberts S, Welch S, Johnstone E, Murphy M, Griffiths S et al.(2004).
Effectiveness of nicotine patches in relation to genotype in women versus men: randomised controlled trial. BMJ
vol. 328,
(7446)
989-990.
Johnstone E, Brown K, Saunders C, Roberts K, Drury M, Walton R, Murphy M(2004).
Level of nicotine replacement during a quit-smoking attempt. NICOTINE & TOBACCO RESEARCH
vol. 6,
(2)
377-379.
Johnstone EC, Yudkin PL, Hey K, Roberts SJ, Welch SJ, Murphy MF, Griffiths SE, Walton RT(2004).
Genetic variation in dopaminergic pathways and short-term effectiveness of the nicotine patch. Pharmacogenetics
vol. 14,
(2)
83-90.
David SP, Eaton CB, Taylor JS, Stamp MJ, Cyr M, Siegel B, Gramling R, Walton R(2004).
Envisaging and applying a unifying three-dimensional theoretical framework for generalist physicians. Medicine and health, Rhode Island
vol. 87,
Article 11,
336-336.
Murphy M, Johnstone EC, Walton RT(2004).
Genes, nicotine addiction, smoking behaviour and cancer.
Yudkin P, Hey K, Roberts S, Welch S, Murphy M, Walton R(2003).
Abstinence from smoking eight years after participation in randomised controlled trial of nicotine patch. BMJ
vol. 327,
(7405)
28-29.
Munafò MR, Clark TG, Moore LR, Payne E, Walton R, Flint J(2003).
Genetic polymorphisms and personality in healthy adults: a systematic review and meta-analysis. Mol Psychiatry
vol. 8,
(5)
471-484.
Ahmad T, Zhang LN, Gogus F, Wallace G, Yang XS, Madanat W, James T, Neville M et al. (2003).
NOD2/CARD15: a genetic link between Behcet's disease (BD) and Crohn's disease (CD)?. GASTROENTEROLOGY.
vol. 124,
A373-A373.
Ahmad T, Neville M, Marshall SE, Armuzzi A, Mulcahy-Hawes K, Crawshaw J, Sato H, Ling K-L et al.(2003).
Haplotype-specific linkage disequilibrium patterns define the genetic topography of the human MHC. Hum Mol Genet
vol. 12,
(6)
647-656.
Ahmad T, Wallace GR, James T, Neville M, Bunce M, Mulcahy-Hawes K, Armuzzi A, Crawshaw J et al.(2003).
Mapping the HLA association in Behçet's disease: a role for tumor necrosis factor polymorphisms?. Arthritis Rheum
vol. 48,
(3)
807-813.
Walton RT, Harvey E, Dovey S, Freemantle N(2003).
Computerised advice on drug dosage to improve prescribing practice. The Cochrane Library
David SP, Niaura R, Papandonatos GD, Shadel WG, Burkholder GJ, Britt DM, Day A, Stumpff J et al.(2003).
Does the DRD2-Taq1 A polymorphism influence treatment response to bupropion hydrochloride for reduction of the nicotine withdrawal syndrome?. Nicotine & tobacco research
vol. 5,
Article 6,
935-942.
Johnstone EC, Clark TG, Griffiths S-E, Murphy MF, Walton RT(2002).
Polymorphisms in dopamine metabolic enzymes and tobacco consumption in smokers: seeking confirmation of the association in a follow-up study. Pharmacogenetics
vol. 12,
(7)
585-587.
Walton R, McKinney E, Marshall S, Murphy M, Welsh K (2002).
Genetic indicators of tobacco consumption.
no. EP20000977718,
Murphy MFG, Hey K, Johnstone E, Munafo M, Walton R, Willis B, Harrison PJ(2002).
Bromocriptine use is associated with decreased smoking rates. Addict Biol
vol. 7,
(3)
325-328.
Neville M, Selzer R, Aizenstein B, Maguire M, Hogan K, Walton R, Welsh K, Neri B et al.(2002).
Characterization of cytochrome P450 2D6 alleles using the Invader (TM) system. BIOTECHNIQUES34-+.
David SP, Johnstone E, Griffiths SE, Murphy M, Yudkin P, Mant D, Walton R(2002).
No association between functional catechol O-methyl transferase 1947A > G polymorphism and smoking initiation, persistent smoking or smoking cessation. PHARMACOGENETICS
vol. 12,
(3)
265-268.
Li JH, Yang XS, Cullen S, Lin KL, Armuzzi A, Ahmad T, Neville MJ, Walton R et al.(2002).
The intercellular adhesion molecule-1 polymorphisms in IBD. GUT
vol. 50,
A47-A47.
Murphy M, Walton R(2002).
22 Pharmacogenomics of Tobacco Addiction Elaine Johnstone, Marcus Munaf6, Matt Neville, Sian Griffiths. Pharmacogenomics: the search for individualized therapies443-443.
Johnstone EC, York EE, Walton RT(2002).
Genetic testing: the future of smoking cessation therapy?. Expert Rev Mol Diagn
vol. 2,
(1)
60-68.
Li JH, Yang XS, Cullen S, Lin KL, Armuzzi A, Ahmad T, Neville MJ, Walton R et al. (2002).
The intercellular adhesion molecule-1 polymorphisms in IBD. GASTROENTEROLOGY.
vol. 122,
A301-A302.
Neville M, Walton R, Aizenstein B, Maguire M, Seltzer R, Hogan K, Neri B, de Arruda M(2001).
Characterisation of cytochrome p450 polymorphisms using the Invader system (R). AMERICAN JOURNAL OF HUMAN GENETICS
vol. 69,
(4)
469-469.
Yudkin P, Hey K, Roberts S, Welch S, Johnstone E, Murphy M, Griffiths S, Jones L et al.(2001).
Is giving up smoking on the nicotine patch related to genotype?. BEHAV GENET
vol. 31,
(5)
475-475.
Munafo M, Walton R, Johnstone E, Yudkin P, Murphy M, Stead L, Cardon L(2001).
The genetic basis for tobacco dependence: A systematic review. BEHAVIOR GENETICS
vol. 31,
(5)
461-462.
WALTON R, MCKINNEY E, MARSHALL S, MURPHY M, WELSH K, others (2001).
GENETIC INDICATORS OF TOBACCO CONSUMPTION.
Munafò M, Johnstone E, Murphy M, Walton R(2001).
New directions in the genetic mechanisms underlying nicotine addiction. Addict Biol
vol. 6,
(2)
109-117.
Walton R, Johnstone E, Munafò M, Neville M, Griffiths S(2001).
Genetic clues to the molecular basis of tobacco addiction and progress towards personalized therapy. Trends Mol Med
vol. 7,
(2)
70-76.
McKinney EF, Walton RT, Yudkin P, Fuller A, Haldar NA, Mant D, Murphy M, Welsh KI et al.(2000).
Association between polymorphisms in dopamine metabolic enzymes and tobacco consumption in smokers. Pharmacogenetics
vol. 10,
(6)
483-491.
Emery J, Walton R, Murphy M, Austoker J, Yudkin P, Chapman C, Coulson A, Glasspool D et al.(2000).
Computer support for interpreting family histories of breast and ovarian cancer in primary care: comparative study with simulated cases. BMJ
vol. 321,
(7252)
28-32.
Emery J, Walton R, Coulson A, Glasspool D, Ziebland S, Fox J(1999).
Computer support for recording and interpreting family histories of breast and ovarian cancer in primary care (RAGs): qualitative evaluation with simulated patients. BMJ
vol. 319,
(7201)
32-36.
Walton R, Dovey S, Harvey E, Freemantle N(1999).
Computer support for determining drug dose: systematic review and meta-analysis. BMJ: British Medical Journal
vol. 318,
(7189)
984-990.
Walton R, Dovey S, Harvey E, Freemantle N(1999).
Computer support may be beneficial for determining drug dosage. Inpharma Weekly
vol. 1183,
(1)
Walton R(1998).
A computerized decision-support system helped trainee doctors control the dosage of an oral anticoagulant. Evidence-based Healthcare
vol. 2,
Article 2,
47-47.
Walton RT, others(1998).
Computerised decision support systems to give advice to doctors about drug therapy.
Walton RT, Gierl C, Yudkin P, Mistry H, Vessey MP, Fox J(1997).
Evaluation of computer support for prescribing (CAPSULE) using simulated cases. BMJ
vol. 315,
(7111)
791-795.
WYATT J, WALTON R(1995).
COMPUTER-BASED PRESCRIBING - IMPROVES DECISION-MAKING AND REDUCES COSTS. BRITISH MEDICAL JOURNAL
vol. 311,
(7014)
1181-1182.
Wyatt J, Walton R(1995).
Computer based prescribing. BMJ
vol. 311,
Article 7014,
1181-1182.
BARAHONA P, WALTON R, ILIC Z, DASILVA JF(1995).
DEEP MEDICAL KNOWLEDGE TO DESIGN CLINICAL GUIDELINES. COMPUTER METHODS AND PROGRAMS IN BIOMEDICINE
vol. 48,
(1-2)
27-34.
Walton R, Ilic Z(1995).
Knowledge engineering for drug prescribing guidelines. Stud Health Technol Inform
vol. 16,
75-85.
WALTON R, RANDALL T(1994).
COMMUNICATION IN THE YEAR-2000. BRITISH JOURNAL OF GENERAL PRACTICE
vol. 44,
(387)
434-435.
WALTON R, FOWLER G(1994).
ADVANTAGES OF GENERAL-PRACTICE. NATURE
vol. 371,
(6493)
98-98.
Smale A, Pitty D, Randall T, Walton R(1994).
Decision Support: A Real Return for Entering Clinical Data.
Walton R, Randall T(1992).
Decision analysis in medicine. BMJ: British Medical Journal
vol. 304,
(6840)
1511-1512.